| Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer Y Malam, M Loizidou, AM Seifalian Trends in pharmacological sciences 30 (11), 592-599, 2009 | 1668 | 2009 |
| The role of nitric oxide in cancer W Xu, LZ Liu, M Loizidou, M Ahmed, IG Charles Cell research 12 (5), 311-320, 2002 | 974 | 2002 |
| Handbook of biologically active peptides A Kastin Academic press, 2013 | 948 | 2013 |
| Toxicology and clinical potential of nanoparticles L Yildirimer, NTK Thanh, M Loizidou, AM Seifalian Nano today 6 (6), 585-607, 2011 | 798 | 2011 |
| Integrin alpha 6/beta 4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion. A Sonnenberg, J Calafat, H Janssen, H Daams, ... The Journal of cell biology 113 (4), 907-917, 1991 | 707 | 1991 |
| 3D tumour models: novel in vitro approaches to cancer studies A Nyga, U Cheema, M Loizidou Journal of cell communication and signaling 5, 239-248, 2011 | 521 | 2011 |
| Endothelin-1: a multifunctional molecule in cancer K Grant, M Loizidou, I Taylor British journal of cancer 88 (2), 163-166, 2003 | 231 | 2003 |
| Increased endothelin-1 in colorectal cancer and reduction of tumour growth by ETA receptor antagonism E Asham, A Shankar, M Loizidou, S Fredericks, K Miller, PB Boulos, ... British journal of cancer 85 (11), 1759-1763, 2001 | 167 | 2001 |
| Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy MJ Bovis, JH Woodhams, M Loizidou, D Scheglmann, SG Bown, ... Journal of Controlled Release 157 (2), 196-205, 2012 | 152 | 2012 |
| Role of the endothelin axis and its antagonists in the treatment of cancer A Bagnato, M Loizidou, BR Pflug, J Curwen, J Growcott British journal of pharmacology 163 (2), 220-233, 2011 | 147 | 2011 |
| Raised endothelin 1 levels in patients with colorectal liver metastases A Shankar, M Loizidou, G Aliev, S Fredericks, D Holt, PB Boulos, ... British journal of surgery 85 (4), 502-506, 1998 | 122 | 1998 |
| Endothelin-1 and angiogenesis in cancer J Knowles, M Loizidou, I Taylor Current vascular pharmacology 3 (4), 309-314, 2005 | 118 | 2005 |
| Positron emission tomography and colorectal cancer THA Arulampalam, DC Costa, M Loizidou, D Visvikis, PJ Ell, I Taylor British journal of surgery 88 (2), 176-189, 2001 | 105 | 2001 |
| Organic nanocarriers for cancer drug delivery V López-Dávila, AM Seifalian, M Loizidou Current opinion in pharmacology 12 (4), 414-419, 2012 | 104 | 2012 |
| A novel tissue engineered three-dimensional in vitro colorectal cancer model A Nyga, M Loizidou, M Emberton, U Cheema Acta biomaterialia 9 (8), 7917-7926, 2013 | 102 | 2013 |
| Cellular glycosylation affects Herceptin binding and sensitivity of breast cancer cells to doxorubicin and growth factors D Peiris, AF Spector, H Lomax-Browne, T Azimi, B Ramesh, M Loizidou, ... Scientific reports 7 (1), 43006, 2017 | 100 | 2017 |
| Helix pomatia agglutinin binding is a useful prognostic indicator in colorectal carcinoma U Schumacher, D Higgs, M Loizidou, R Pickering, A Leathem, I Taylor Cancer 74 (12), 3104-3107, 1994 | 96 | 1994 |
| Importance of the omentum in the development of intra-abdominal metastases RJ Lawrance, M Loizidou, AJ Cooper, P Alexander, I Taylor Journal of British Surgery 78 (1), 117-119, 1991 | 83 | 1991 |
| Engineering a vascularised 3D in vitro model of cancer progression T Magdeldin, V López-Dávila, J Pape, GWW Cameron, M Emberton, ... Scientific reports 7 (1), 44045, 2017 | 80 | 2017 |
| Endothelin-1 and tumour development EH Asham, M Loizidou, I Taylor European Journal of Surgical Oncology (EJSO) 24 (1), 57-59, 1998 | 79 | 1998 |